Activist investor pushes Bayer to separate crop science, consumer health from pharma
An activist investor is urging Bayer to split its three main units and shake up the supervisory board as shareholders are set to meet for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
